Ad is loading...
BRUMX
Price
$17.61
Change
-$0.11 (-0.62%)
Updated
Nov 15 closing price
VIVIX
Price
$68.70
Change
-$0.26 (-0.38%)
Updated
Nov 15 closing price
Ad is loading...

BRUMX vs VIVIX

Header iconBRUMX vs VIVIX Comparison
Open Charts BRUMX vs VIVIXBanner chart's image
MFS Blended Research Value Equity R4
Price$17.61
Change-$0.11 (-0.62%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index I
Price$68.70
Change-$0.26 (-0.38%)
VolumeN/A
CapitalizationN/A
BRUMX vs VIVIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BRUMX vs. VIVIX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRUMX is a Sell and VIVIX is a StrongSell.

FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 184B vs. BRUMX (295M). VIVIX pays higher dividends than BRUMX: VIVIX (2.37) vs BRUMX (1.32). BRUMX was incepted earlier than VIVIX: BRUMX (9 years) vs VIVIX (26 years). BRUMX is a more actively managed with annual turnover of: 51.00 vs. VIVIX (10.00). BRUMX has a lower initial minimum investment than VIVIX: BRUMX (0) vs VIVIX (5000000). VIVIX (25.54) and BRUMX (25.16) have marching annual gain over last year. VIVIX return over 5 years is better than : 50.79 vs. BRUMX (40.00).
BRUMXVIVIXBRUMX / VIVIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years26 years-
Gain YTD17.55717.92298%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets295M184B0%
Annual Yield % from dividends1.322.3756%
Returns for 1 year25.1625.5498%
Returns for 3 years6.8121.5732%
Returns for 5 years40.0050.7979%
Returns for 10 yearsN/A110.50-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EXR164.561.13
+0.69%
Extra Space Storage
PALT1.83N/A
N/A
Paltalk
AOMR9.80-0.06
-0.61%
Angel Oak Mortgage REIT
DLO9.89-0.31
-3.04%
DLocal Limited
GYRE13.12-0.72
-5.20%
Gyre Therapeutics